Drug Shortage Report for ANDROGEL
| Report ID | 192956 |
| Drug Identification Number | 02249499 |
| Brand name | ANDROGEL |
| Common or Proper name | TESTOSTERONE |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TESTOSTERONE |
| Strength(s) | 12.5MG |
| Dosage form(s) | GEL |
| Route of administration | TRANSDERMAL TRANSDERMAL |
| Packaging size | 1.25G |
| ATC code | G03BA |
| ATC description | ANDROGENS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-05-26 |
| Actual start date | |
| Estimated end date | 2023-06-06 |
| Actual end date | 2023-05-29 |
| Shortage status | Resolved |
| Updated date | 2023-05-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-05-31 | French | Compare |
| v4 | 2023-05-31 | English | Compare |
| v3 | 2023-05-27 | English | Compare |
| v2 | 2023-05-24 | French | Compare |
| v1 | 2023-05-24 | English | Compare |
Showing 1 to 5 of 5